Metoprolol is a beta 1 -selective (cardio selective) adrenergic receptor blocking agent, for oral administration, available as extended release tablet. BETABESTT-XL has been formulated to provide a controlled and predictable release of metoprolol for once daily administration.
Each tablet contains:
Extended release metoprolol succinate - 25 mg
Hypertension: The usual initial dosage is 50 to 100 mg daily in a single dose. The dosage may increase at weekly intervals until optimum blood pressure reduction is achieved.
Angina pectoris: The usual initial dosage is 100 mg daily, given in single dose. The dosage may be gradually increased at weekly intervals until optimum clinical response has been obtained
Heart failure: The recommended starting dose of BETABEST-XL is 25 mg once daily for two weeks in patients with NYHA class II heart failure.
Tiredness, dizziness, depression, headache, Shortness of breath, bradycardia, diarrhea, nausea, dry mouth, constipation, flatulence.
Severe bradycardia, Heart block greater than first degree, Cardiogenic shock Refractory heart failure, Sick sinus syndrome (unless a permanent pacemaker is in place), Hypersensitivity to any component of this product.
Betabest XL is available as a strip of 10 tablets.